Vestibo 16mg 30 tablets — Made in Bulgaria — Free Delivery

(Vestibo 16mg)
Vestibo 16mg 30 tablets — Made in Bulgaria — Free Delivery
Availability: 2 - 3 Days
Balkanpharma-Dupnitsa AD Brand: Balkanpharma-Dupnitsa AD

Coupon code -5%: BONUS23

You can apply the coupon in the shopping cart at checkout.

 

Description Vestibo 16mg 30 tablets — Made in Bulgaria — Free Delivery

Product description 

Vestibo is indicated for the treatment of Meniere's disease and syndrome characterized by three main symptoms:
  • dizziness, sometimes accompanied by nausea and vomiting;
  • hearing loss (hard of hearing)
  • tinnitus.
Vestibo is also prescribed for the symptomatic treatment of vestibular vertigo of various origins.

Compound

active ingredient: betahistine;
1 tablet contains betahistine dihydrochloride 16 mg;
excipients: povidone, microcrystalline cellulose, lactose, colloidal silicon dioxide, crospovidone, stearic acid.

Contraindications

Hypersensitivity to or to any of the excipients of the preparation.
Pheochromocytoma.

Application features

Use during pregnancy or lactation
Pregnancy. There are insufficient data on the use of betahistine in pregnant women.
The results of animal studies are insufficient to assess the effect on pregnancy, embryo/fetal development, childbirth and postnatal development. The potential risk to humans is unknown. Betahistine should not be used during pregnancy unless clearly necessary.
breastfeeding period. It is not known whether betahistine passes into breast milk. Animal studies on the penetration of betahistine into milk have not been conducted. The benefit to the mother should be weighed against the benefits of breastfeeding and the potential risk to the baby.
Children
Due to the lack of data on the safety and efficacy of betahistine, the preparation is not recommended for children (under the age of 18 years).
The ability to influence the reaction rate when driving vehicles or operating other mechanisms
Betahistine is indicated for the treatment of Meniere's syndrome, which is characterized by a triad of main symptoms: dizziness, hearing loss, tinnitus, as well as for the symptomatic treatment of vestibular vertigo. Both conditions can negatively affect the ability to drive and use machines. According to clinical studies that studied the effect on the ability to drive a car and work with other mechanisms, betahistine did not affect or had an insignificant effect on this ability.

Dosage and administration

The daily dose for adults is 24-48 mg, evenly distributed for admission during the day.
The dose should be selected individually, depending on the effect. Reduction of symptoms is sometimes observed only after two to three weeks of treatment. The best results are sometimes achieved when taking the preparation for several months. There is evidence that treatment early in the disease prevents disease progression and/or hearing loss in later stages.

Overdose

There are several cases of preparation overdose. Some patients experienced mild to moderate symptoms (nausea, drowsiness, abdominal pain) after taking the preparation at a dose of up to 640 mg. More serious complications (convulsions, cardiopulmonary complications) have been observed with the deliberate intake of high doses of betahistine, especially in combination with an overdose of other preparations.
Treatment
Treatment of overdose should include standard supportive measures.

Adverse reactions

The following adverse reactions were observed in patients with such a frequency: very often (≥ 1/10), often (≥1/100 to <1/10), infrequent (from ≥1/1000 to <1/100), rare (from ≥ 1/10000 to <1/1000), rare (<1/10000).
From the gastrointestinal tract
Often: nausea and dyspepsia.
From the side of the nervous system
Often: headache.
Adverse reactions, the frequency of which is unknown.
From the side of the immune system
Hypersensitivity reactions such as anaphylaxis.
From the gastrointestinal tract
Complaints of minor stomach upsets (vomiting, gastrointestinal pain, bloating and flatulence). These side effects usually disappear when the preparation is taken with food or when the dose is reduced.
From the skin and subcutaneous tissue
Hypersensitivity reactions of the skin and subcutaneous fat have been observed, in particular angioedema, rash, itching and urticaria.
Interaction with other medicinal products and other forms of interaction
In vivo studies aimed at studying interactions with other preparations have not been conducted. Based on in vitro study data, suppression of cytochrome P450 enzyme activity in vivo is not expected.
In vitro data suggest that betahistine metabolism is inhibited by preparations that inhibit monoamine oxidase (MAO) activity, including MAO subtype B (eg, selegiline). It is recommended to be careful with the simultaneous use of betahistine and MAO inhibitors (including selectively subtype B MAO).
Since betahistine is a histamine analog, the interaction of betahistine with antihistamines could theoretically affect the effectiveness of one of these preparations.

Storage conditions

Store in original packaging at temperatures not exceeding 25°C.
Keep out of the reach of children.
Shelf life - 3 years.

Tags: Vestibo

Reviews Vestibo 16mg 30 tablets — Made in Bulgaria — Free Delivery

There are no reviews for this product.

Write a review

Buyers Online